Seaport Therapeutics, Inc.Seaport Therapeutics, Inc.
SPTXSeaport Therapeutics, Inc. is a clinical-stage therapeutics company, which engages in the provision of inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company was founded on April 1, 2024 and is headquartered in Boston, MA.
Market cap
$1.2BNo data
Revenue
No dataNo data
Net income
No dataNo data
Free cash flow
No dataNo data
Seaport Therapeutics reported negative free and operating cash flow with no available net income, while high unused balance-sheet capacity accompanied uniformly negative returns on deployed capital.
As of 2026-06-30Market
Listed stock
SPTXPriceNasdaqLoading…Loading…1Y